Sunshine Biopharma, Inc 4
4 · Sunshine Biopharma, Inc · Filed Jan 22, 2015
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Other
Common Stock
2015-01-09$0.02/sh+150,000$3,000→ 384,373 total - Other
Common Stock
2015-01-09$0.02/sh−1,200,000$24,000→ 30,317,694 total(indirect: Owned by Advanomics Corporation, an entity controlled by Reporting Person.)
Footnotes (2)
- [F1]Advanomics Corporation, an entity controlled by Reporting Person, acquired intellectual properties in exchange for the transfer of 1,200,000 shares of the Issuer's Common Stock to 5 entities or persons, 150,000 shares of which having been transferred to the Reporting Person in the transaction. See Footnote 2.
- [F2]Reporting Person acquired 150,000 shares of the Issuer's Common Stock from Advanomics Corporation, an entity controlled by the Reporting Person, in exchange for interests in intellectual properties transferred to Advanomics Corporation. See Footnote 1.